 | • レポートコード：PMR210107 • 出版社/出版日：Persistence Market Research / 2020年11月19日 • レポート形態：英文、PDF、233ページ • 納品方法：Eメール • 産業分類：ヘルスケア |
| Single User（1名用） | ￥676,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence（同一拠点内共有可） | ￥1,048,800 (USD7,600) | ▷ お問い合わせ |
| Enterprise wide（複数拠点内共有可） | ￥1,462,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料では、世界の単一ドメイン抗体プラットフォーム市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、市場価格分析・予測、プラットフォーム種類別（マルチスペシフィック単一ドメイン抗体、二重特異性単一ドメイン抗体、多価単一ドメイン抗体、単一特異性単一ドメイン抗体）分析、動物由来別（ラクダ、サメ）分析、用途別（診断開発、治療法開発、研究・開発活動）分析、エンドユーザー別（診断研究所、臨床検査室、学術・研究機関、製薬・バイオテクノロジー企業）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・市場価格分析・予測 ・世界の単一ドメイン抗体プラットフォーム市場規模：プラットフォーム種類別（マルチスペシフィック単一ドメイン抗体、二重特異性単一ドメイン抗体、多価単一ドメイン抗体、単一特異性単一ドメイン抗体） ・世界の単一ドメイン抗体プラットフォーム市場規模：動物由来別（ラクダ、サメ） ・世界の単一ドメイン抗体プラットフォーム市場規模：用途別（診断開発、治療法開発、研究・開発活動） ・世界の単一ドメイン抗体プラットフォーム市場規模：エンドユーザー別（診断研究所、臨床検査室、学術・研究機関、製薬・バイオテクノロジー企業） ・世界の単一ドメイン抗体プラットフォーム市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Single-Domain Antibody Platforms Market – Scope of Report
A latest publication by Persistence Market Research (PMR) on the global single-domain antibody platforms market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global single-domain antibody platforms market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the single-domain antibody platforms market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.
Important indicators for successful growth of the single-domain antibody platforms market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR). This research study can support readers to know the demand for single-domain antibody platforms and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the single-domain antibody platforms market space, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the single-domain antibody platforms market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the single-domain antibody platforms market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the single-domain antibody platforms market are also included in the current study. Depending on potential developments in the single-domain antibody platforms market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the single-domain antibody platforms industry can be aided in making suitable company choices to achieve traction in the market. Key Questions Answered in PMR’s Single-Domain Antibody Platforms Market Report
Which regions will continue to remain the most profitable regional markets for single-domain antibody platforms market players?
Which factors will induce a change in the demand for single-domain antibody platforms during the assessment period?
How will changing trends impact the single-domain antibody platforms market?
How can market players capture the low-hanging opportunities in the single-domain antibody platforms market in developed regions?
What are the winning strategies of stakeholders in the single-domain antibody platforms market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and might tackle while investing in the single-domain antibody platforms market?
What are the developmental trends in single-domain antibody platform sectors that will impact the market?
How can businesses in the single-domain antibody platforms market avail growth the opportunities in developed and emerging sectors?
Single-Domain Antibody Platforms Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the single-domain antibody platforms market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the single-domain antibody platforms market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the single-domain antibody platforms market, and makes PMR’s projections on the growth prospects of the market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption Rate/Usage Analysis- Key Statistics
4.2. Key Promotional Strategies, By Key Manufacturers
4.3. Key Regulations, By Region
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Market Outlook
5.1.3. Global Life Science Market Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Research Activities
5.2.2. Key Players Historical Growth
5.2.3. Market Consolidation Activities
5.2.4. New Products Launches
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. Quarter by Quarter Forecast
6.5. Projected recovery Quarter
6.6. COVID-19 Testing and Management
7. Global Single-Domain Antibody Platforms Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030, by Platform Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Platform Type, 2015-2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Platform Type, 2020-2030
8.3.1. Multi-specific Single-Domain Antibody
8.3.2. Bispecific Single-Domain Antibody
8.3.3. Multivalent Single-Domain Antibody
8.3.4. Mono-specific Single-Domain Antibody
8.4. Market Attractiveness Analysis by Platform Type
9. Global Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030, by Animal Source
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Animal Source, 2015-2019
9.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Animal Source, 2020-2030
9.3.1. Camelids
9.3.1.1. Camels
9.3.1.2. Llama
9.3.1.3. Alpacas
9.3.2. Shark
9.4. Market Attractiveness Analysis By Platform Type
10. Global Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and By Application, 2015-2019
10.3. Current and Future Market Size (US$ Mn) and Forecast By Application, 2020-2030
10.3.1.1. Diagnostic Development
10.3.1.2. Therapeutic Development
10.3.1.3. Research & Developmental Activities
10.4. Market Attractiveness Analysis by Application
11. Global Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
11.3.1.1. Diagnostic Laboratories
11.3.1.2. Clinical Laboratories
11.3.1.3. Academic & Research Institutes
11.3.1.4. Pharmaceutical & Biotechnology Companies
11.4. Market Attractiveness Analysis By End User
12. Global Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Platform Type
13.3.3. By Animal Source
13.3.4. By Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints – Impact Analysis
14. Latin America Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Platform Type
14.3.3. By Animal Source
14.3.4. By Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints – Impact Analysis
15. Europe Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Platform Type
15.3.3. By Animal Source
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints – Impact Analysis
16. South Asia Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Platform Type
16.3.3. By Animal Source
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints – Impact Analysis
17. East Asia Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Platform Type
17.3.3. By Animal Source
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints – Impact Analysis
18. Oceania Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Platform Type
18.3.3. By Animal Source
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints – Impact Analysis
19. Middle East and Africa Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Platform Type
19.3.3. By Animal Source
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints – Impact Analysis
20. Key and Emerging Countries Single-Domain Antibody Platforms Market Analysis 2015-2019 and Forecast 2020-2030
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. U.S. Single-Domain Antibody Platforms Market Analysis
20.2.1. By Platform Type
20.2.2. By Animal Source
20.2.3. By Application
20.2.4. By End User
20.3. Canada Single-Domain Antibody Platforms Market Analysis
20.3.1. By Platform Type
20.3.2. By Animal Source
20.3.3. By Application
20.3.4. By End User
20.4. Mexico Single-Domain Antibody Platforms Market Analysis
20.4.1. By Platform Type
20.4.2. By Animal Source
20.4.3. By Application
20.4.4. By End User
20.5. Brazil Single-Domain Antibody Platforms Market Analysis
20.5.1. By Platform Type
20.5.2. By Animal Source
20.5.3. By Application
20.5.4. By End User
20.6. U.K. Single-Domain Antibody Platforms Market Analysis
20.6.1. By Platform Type
20.6.2. By Animal Source
20.6.3. By Application
20.6.4. By End User
20.7. Germany Single-Domain Antibody Platforms Market Analysis
20.7.1. By Platform Type
20.7.2. By Animal Source
20.7.3. By Application
20.7.4. By End User
20.8. France Single-Domain Antibody Platforms Market Analysis
20.8.1. By Platform Type
20.8.2. By Animal Source
20.8.3. By Application
20.8.4. By End User
20.9. Italy Single-Domain Antibody Platforms Market Analysis
20.9.1. By Platform Type
20.9.2. By Animal Source
20.9.3. By Application
20.9.4. By End User
20.10. Spain Single-Domain Antibody Platforms Market Analysis
20.10.1. By Platform Type
20.10.2. By Animal Source
20.10.3. By Application
20.10.4. By End User
20.11. Russia Single-Domain Antibody Platforms Market Analysis
20.11.1. By Platform Type
20.11.2. By Animal Source
20.11.3. By Age Group
20.11.4. By End User
20.12. China Single-Domain Antibody Platforms Market Analysis
20.12.1. By Platform Type
20.12.2. By Animal Source
20.12.3. By Application
20.12.4. By End User
20.13. Japan Single-Domain Antibody Platforms Market Analysis
20.13.1. By Platform Type
20.13.2. By Animal Source
20.13.3. By Application
20.13.4. By End User
20.14. South Korea Single-Domain Antibody Platforms Market Analysis
20.14.1. By Platform Type
20.14.2. By Animal Source
20.14.3. By Application
20.14.4. By End User
20.15. India Single-Domain Antibody Platforms Market Analysis
20.15.1. By Platform Type
20.15.2. By Animal Source
20.15.3. By Application
20.15.4. By End User
20.16. Indonesia Single-Domain Antibody Platforms Market Analysis
20.16.1. By Platform Type
20.16.2. By Animal Source
20.16.3. By Application
20.16.4. By End User
20.17. Australia Single-Domain Antibody Platforms Market Analysis
20.17.1. By Platform Type
20.17.2. By Animal Source
20.17.3. By Application
20.17.4. By End User
20.18. New Zealand Single-Domain Antibody Platforms Market Analysis
20.18.1. By Platform Type
20.18.2. By Animal Source
20.18.3. By Application
20.18.4. By End User
20.19. GCC Countries Single-Domain Antibody Platforms Market Analysis
20.19.1. By Platform Type
20.19.2. By Animal Source
20.19.3. By Application
20.19.4. By End User
20.20. South Africa Single-Domain Antibody Platforms Market Analysis
20.20.1. By Platform Type
20.20.2. By Animal Source
20.20.3. By Application
20.20.4. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1.1. Regional footprint of Players
21.3.1.2. Platform Type foot print by Players
21.3.1.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Creative BioLabs A
22.3.1.1. Overview
22.3.1.2. Platform Type Portfolio
22.3.1.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. Analyst Commentary
22.3.1.6. Strategy Overview
22.3.1.6.1. Marketing Strategy
22.3.1.6.2. Platform Type Strategy
22.3.1.6.3. Channel Strategy
22.3.2. Synbio Technologies
22.3.2.1. Overview
22.3.2.2. Platform Type Portfolio
22.3.2.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.2.4. Sales Footprint
22.3.2.5. Analyst Commentary
22.3.2.6. Strategy Overview
22.3.2.6.1. Marketing Strategy
22.3.2.6.2. Platform Type Strategy
22.3.2.6.3. Channel Strategy
22.3.3. ProSci Incorporated
22.3.3.1. Overview
22.3.3.2. Platform Type Portfolio
22.3.3.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.3.4. Sales Footprint
22.3.3.5. Analyst Commentary
22.3.3.6. Strategy Overview
22.3.3.6.1. Marketing Strategy
22.3.3.6.2. Platform Type Strategy
22.3.3.6.3. Channel Strategy
22.3.4. BioCat GmbH
22.3.4.1. Overview
22.3.4.2. Platform Type Portfolio
22.3.4.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.4.4. Sales Footprint
22.3.4.5. Analyst Commentary
22.3.4.6. Strategy Overview
22.3.4.6.1. Marketing Strategy
22.3.4.6.2. Platform Type Strategy
22.3.4.6.3. Channel Strategy
22.3.5. Antibody Design Labs
22.3.5.1. Overview
22.3.5.2. Platform Type Portfolio
22.3.5.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.5.4. Sales Footprint
22.3.5.5. Analyst Commentary
22.3.5.6. Strategy Overview
22.3.5.6.1. Marketing Strategy
22.3.5.6.2. Platform Type Strategy
22.3.5.6.3. Channel Strategy
22.3.6. GenScript
22.3.6.1. Overview
22.3.6.2. Platform Type Portfolio
22.3.6.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.6.4. Sales Footprint
22.3.6.5. Analyst Commentary
22.3.6.6. Strategy Overview
22.3.6.6.1. Marketing Strategy
22.3.6.6.2. Platform Type Strategy
22.3.6.6.3. Channel Strategy
22.3.7. Oak BioSciences, Inc.
22.3.7.1. Overview
22.3.7.2. Platform Type Portfolio
22.3.7.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.7.4. Sales Footprint
22.3.7.5. Analyst Commentary
22.3.7.6. Strategy Overview
22.3.7.6.1. Marketing Strategy
22.3.7.6.2. Platform Type Strategy
22.3.7.6.3. Channel Strategy
22.3.8. Rockland Immunochemicals, Inc
22.3.8.1. Overview
22.3.8.2. Platform Type Portfolio
22.3.8.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.8.4. Sales Footprint
22.3.8.5. Analyst Commentary
22.3.8.6. Strategy Overview
22.3.8.6.1. Marketing Strategy
22.3.8.6.2. Platform Type Strategy
22.3.8.6.3. Channel Strategy
22.3.9. Hybrigenics Services
22.3.9.1. Overview
22.3.9.2. Platform Type Portfolio
22.3.9.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.9.4. Sales Footprint
22.3.9.5. Analyst Commentary
22.3.9.6. Strategy Overview
22.3.9.6.1. Marketing Strategy
22.3.9.6.2. Platform Type Strategy
22.3.9.6.3. Channel Strategy
22.3.10. NeoClone Biotechnology International LLC
22.3.10.1. Overview
22.3.10.2. Platform Type Portfolio
22.3.10.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.10.4. Sales Footprint
22.3.10.5. Analyst Commentary
22.3.10.6. Strategy Overview
22.3.10.6.1. Marketing Strategy
22.3.10.6.2. Platform Type Strategy
22.3.10.6.3. Channel Strategy
22.3.11. Kaneka Eurogentec S.A
22.3.11.1. Overview
22.3.11.2. Platform Type Portfolio
22.3.11.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.11.4. Sales Footprint
22.3.11.5. Analyst Commentary
22.3.11.6. Strategy Overview
22.3.11.6.1. Marketing Strategy
22.3.11.6.2. Platform Type Strategy
22.3.11.6.3. Channel Strategy
22.3.12. ProteoGenix
22.3.12.1. Overview
22.3.12.2. Platform Type Portfolio
22.3.12.3. Profitability by Market Segments (Platform Type/Channel/Region)
22.3.12.4. Sales Footprint
22.3.12.5. Analyst Commentary
22.3.12.6. Strategy Overview
22.3.12.6.1. Marketing Strategy
22.3.12.6.2. Platform Type Strategy
22.3.12.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Table 1: Global Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform TypeTable 2: Global Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Source
Table 3: Global Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 4: Global Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 5: Global Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
Table 6: North America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type
Table 7: North America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources
Table 8: North America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 9: North America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 10: North America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 11: Latin America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type
Table 12: Latin America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources
Table 13: Latin America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 14: Latin America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 15: Latin America Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 16: Europe Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type
Table 17: Europe Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources
Table 18: Europe Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 19: Europe Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 20: Europe Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 21: South Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type
Table 22: South Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources
Table 23: South Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 24: South Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 25: South Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 26: East Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type
Table 27: East Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources
Table 28: East Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 29: East Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 30: East Asia Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 31: Oceania Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type
Table 32: Oceania Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources
Table 33: Oceania Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 34: Oceania Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 35: Oceania Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 36: Middle East and Africa Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Platform Type
Table 37: Middle East and Africa Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Animal Sources
Table 38: Middle East and Africa Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Application
Table 39: Middle East and Africa Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
Table 40: Middle East and Africa Single-Domain Antibody Platforms Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country